Literature DB >> 8749793

Family and client characteristics as predictors of outpatient treatment outcome for adolescent drug abusers.

A S Friedman1, A Terras, C Kreisher.   

Abstract

Adolescent drug abuse clients (N = 176) and their mothers, in six different outpatient drug-free programs, were assessed at admission and at follow-up, 15 months after initiation of treatment. Family therapy sessions were offered in all six programs programs in addition to individual and group counseling. The pretreatment assessment procedures, and thus also the variables analyzed for prediction of treatment outcome, emphasized family measures (including the Family Environment Scale, the Family Adaptability and Cohesion Scale, the Parent-Adolescent Communication Inventory, and other information about the family and the parents). Multiple regression analysis determined which of three demographic variables and 39 other independent pretreatment predictor variables had a significant relationship with each of the six outcome criteria (dependent variables). Four of these outcome criteria were based on client information, and two were based on information provided by the mother. The more positively the family's functioning and relationships were described by the client at pretreatment, the more client improvement was reported by either client or mother at follow-up. Eleven of the 12 predictor variables that were found to be significantly related to any of the treatment outcome criteria were measures, at pretreatment, either of the client's perceptions of family functioning, or of his or her relationship with parents, particularly with the mother. These findings show the power of the family factors as indicators of prognosis. The predictor variable that was found to have the largest number of significant relationships, predicting three of the six outcome criteria, was the "family independence" dimension of the FES (i.e., "The extent to which family members are encouraged to be assertive, self-sufficient"). It appears that the FES instrument may be quite effective for predicting improvements in the behavior of adolescent drug-abusing clients.

Entities:  

Mesh:

Year:  1995        PMID: 8749793     DOI: 10.1016/0899-3289(95)90027-6

Source DB:  PubMed          Journal:  J Subst Abuse        ISSN: 0899-3289


  7 in total

1.  Substance use treatment outcomes for youth: integrating personal and environmental predictors.

Authors:  Kristen G Anderson; Danielle E Ramo; Marya T Schulte; Kevin Cummins; Sandra A Brown
Journal:  Drug Alcohol Depend       Date:  2006-11-07       Impact factor: 4.492

2.  Psychometric Properties of a Revised Form of the Drug-Taking Confidence Questionnaire for Use with Adolescents.

Authors:  Danielle E Ramo; Mark G Myers; Sandra A Brown
Journal:  J Child Adolesc Subst Abuse       Date:  2009-01-01

3.  Identifying treatment response subgroups for adolescent cannabis use.

Authors:  Steven F Babbin; Catherine Stanger; Emily A Scherer; Alan J Budney
Journal:  Addict Behav       Date:  2016-04-02       Impact factor: 3.913

4.  Longitudinal predictors of youth functional improvement in a public mental health system.

Authors:  Charles W Mueller; Ryan Tolman; Charmaine K Higa-McMillan; Eric L Daleiden
Journal:  J Behav Health Serv Res       Date:  2009-03-10       Impact factor: 1.505

5.  Randomized Controlled Trial of an Integrated Family-Based Treatment for Adolescents Presenting to Community Mental Health Centers.

Authors:  Ashli J Sheidow; Kristyn Zajac; Jason E Chapman; Michael R McCart; Tess K Drazdowski
Journal:  Community Ment Health J       Date:  2020-10-29

6.  Predictors of Relapse after Inpatient Opioid Detoxification during 1-Year Follow-Up.

Authors:  Harsh Chalana; Tanu Kundal; Varun Gupta; Amandeep Singh Malhari
Journal:  J Addict       Date:  2016-09-18

7.  Predictors of retention in treatment in a tertiary care de-addiction center.

Authors:  Pradipta Majumder; Siddharth Sarkar; Rishab Gupta; Bichitra Nanda Patra; Yatan Pal Singh Balhara
Journal:  Indian J Psychiatry       Date:  2016 Jan-Mar       Impact factor: 1.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.